04.09.2015
Acino launches the first generic Rivastigmine patch in the USA
Acino’s rivastigmine patch is the first generic alternative to the originator product making the medical treatment of Alzheimer’s more affordable...
News
17.02.2015
Acino welcomes German court ruling on rivastigmine
Acino announces the achievement of another judicial success in the ongoing German intellectual property litigation proceedings regarding its generic rivastigmine...
06.11.2014
Acino receives Frost & Sullivan Award for Enabling Technology Leadership
Acino is proud to be the recipient of the Frost & Sullivan “2014 European Pharmaceutical Drug Delivery Enabling Technology Leadership...
10.09.2014
Delisting of Acino Holding AG from the SIX Swiss Exchange
After the successful completion of the public tender offer of Pharma Strategy Partners for Acino Holding AG on December 12,...
07.07.2014
Cancellation of the remaining publicly held registered shares of Acino Holding AG
With decision dated June 26, 2014, the Cantonal court of Basel-Landschaft has admitted the claim of Pharma Strategy Partners GmbH,...
23.01.2014
Acino: Publicity Duties
After the successful completion of the tender offer of Pharma Strategy Partners for Acino Holding AG (Acino), SIX Exchange Regulation...
07.01.2014
Delisting of Acino Holding AG after cancellation of all publicly held registered shares
On December 20, 2013, SIX Swiss Exchange (SIX) approved Acino Holding AG’s request for the delisting of its registered shares....